Balyasny Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-159,038
| Closed | -$426K | – | 2054 |
|
|
2024
Q1 | $426K | Buy |
159,038
+121,850
| +328% | +$327K | ﹤0.01% | 1529 |
|
|
2023
Q4 | $111K | Buy |
+37,188
| New | +$111K | ﹤0.01% | 1805 |
|
|
2023
Q3 | – | Sell |
-16,039
| Closed | -$22.3K | – | 1883 |
|
|
2023
Q2 | $22.3K | Sell |
16,039
-4,755,321
| -100% | -$6.61M | ﹤0.01% | 1756 |
|
|
2023
Q1 | $7.59M | Buy |
4,771,360
+1,342,223
| +39% | +$2.13M | 0.02% | 678 |
|
|
2022
Q4 | $21.4M | Buy |
3,429,137
+2,633,466
| +331% | +$16.4M | 0.06% | 376 |
|
|
2022
Q3 | $5.33M | Buy |
795,671
+783,700
| +6,547% | +$5.25M | 0.02% | 733 |
|
|
2022
Q2 | $76K | Buy |
+11,971
| New | +$76K | ﹤0.01% | 1865 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1247 |
|
|
2020
Q3 | – | Sell |
-62,282
| Closed | -$3.2M | – | 1142 |
|
|
2020
Q2 | $3.2M | Sell |
62,282
-199,456
| -76% | -$10.2M | 0.03% | 507 |
|
|
2020
Q1 | $8.25M | Buy |
261,738
+11,361
| +5% | +$358K | 0.1% | 258 |
|
|
2019
Q4 | $14.9M | Buy |
250,377
+115,147
| +85% | +$6.87M | 0.09% | 300 |
|
|
2019
Q3 | $4.96M | Sell |
135,230
-26,218
| -16% | -$961K | 0.03% | 484 |
|
|
2019
Q2 | $7.51M | Buy |
+161,448
| New | +$7.51M | 0.05% | 419 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1329 |
|
|
2018
Q4 | – | Sell |
-9,894
| Closed | -$439K | – | 1354 |
|
|
2018
Q3 | $439K | Sell |
9,894
-31,330
| -76% | -$1.39M | ﹤0.01% | 1194 |
|
|
2018
Q2 | $1.62M | Sell |
41,224
-109,217
| -73% | -$4.28M | 0.01% | 836 |
|
|
2018
Q1 | $10.9M | Sell |
150,441
-252,723
| -63% | -$18.3M | 0.05% | 428 |
|
|
2017
Q4 | $26.5M | Buy |
403,164
+10,014
| +3% | +$659K | 0.08% | 295 |
|
|
2017
Q3 | $19.7M | Buy |
393,150
+192,667
| +96% | +$9.66M | 0.08% | 285 |
|
|
2017
Q2 | $9.28M | Buy |
200,483
+150,983
| +305% | +$6.99M | 0.04% | 473 |
|
|
2017
Q1 | $1.75M | Buy |
+49,500
| New | +$1.75M | 0.01% | 788 |
|